Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 881-900
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Josh Felker Co-Founder at Nascent | Montreal, Canada | Family OfficeVenture capital | AIConsumer | ||
 Ethan Shin Investor at Kb Investment | Cambridge, United States | Private equityVenture capital | AIClimate | ||
 Umesh Shanghvi angel investor | Mumbai, India | Angel | AIFinTech | ||
 Brandon Drew angel investor and operator angel | Smyrna, United States | AngelOperator angel | HardwareHealthcare | ||
 Jonathan Silverstein President and Co-Founder at The Silverstein Foundation for Parkinson's with GBA | New York, United States | Family OfficePrivate equity | AIHardware | ||
 Pranav Seshadri Investor at T.Rx Capital | United States | Venture capital | AICommerce | ||
 Florian Reinaud Investor at Redmile Group | Paris, France | Private equityVenture capital | Healthcare | ||
 John Ballantyne angel investor and operator angel | Fargo, United States | AngelOperator angel | Healthcare | ||
 Dan Cowell angel investor and operator angel | Cambridge, United Kingdom | AngelOperator angel | Healthcare | ||
 Dan Vaughn angel investor and operator angel | Encinitas, United States | AngelOperator angel | AIHealthcare | ||
 Spencer Chandlee Investor at Cardinal Partners | New York, United States | Venture capitalVenture debt | FinTechHealthcare | ||
 Sabina Sperisen Investor at Lichtsteiner Foundation | Switzerland | Family Office | Healthcare | ||
 Amine Marouf Expert at Eit Health | Paris, France | Accelerator | AIHealthcare | ||
 Michael Liang Investor at InVivium Capital | Chicago, United States | Private equityVenture capital | AIClimate | ||
 Sanne Weijzen Head of Cell Therapy Business and Portfolio Strategy at AstraZeneca | Hilversum, Netherlands | Corporate VC | Healthcare | ||
 David Schenkein Board Member at Regeneron | Boston, United States | Corporate VCVenture capital | AICommerce | ||
 Neil Wolff General Partner at VIVE Venture Capital | San Francisco, United States | Private equityVenture capital | AIClimate | ||
 Brian Baynes Founder at Petri | Boston, United States | Venture capital | AIFinTech | ||
 Deborah Buresh Jackson Founder at Plum Alley | New York, United States | Syndicate / Angel groupVenture capital | AIClimate | ||
 Louis Scaramanga Affiliated at Reference Capital | Geneva, Switzerland | Family OfficeFund of funds | AIEducation |
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal